• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Predicting coronavirus disease 2019 severity using explainable artificial intelligence techniques

tetano

Editor, Senior Moderator
Sci Rep


. 2025 Mar 19;15(1):9459.
doi: 10.1038/s41598-025-85733-5. Predicting coronavirus disease 2019 severity using explainable artificial intelligence techniques

Takuya Ozawa[SUP] #[/SUP][SUP] 1 [/SUP], Shotaro Chubachi[SUP] #[/SUP][SUP] 2 [/SUP], Ho Namkoong[SUP] #[/SUP][SUP] 3 [/SUP], Shota Nemoto[SUP] 4 [/SUP], Ryo Ikegami[SUP] 4 [/SUP], Takanori Asakura[SUP] 1 5 6 [/SUP], Hiromu Tanaka[SUP] 1 [/SUP], Ho Lee[SUP] 1 [/SUP], Takahiro Fukushima[SUP] 1 [/SUP], Shuhei Azekawa[SUP] 1 [/SUP], Shiro Otake[SUP] 1 [/SUP], Kensuke Nakagawara[SUP] 1 [/SUP], Mayuko Watase[SUP] 1 [/SUP], Katsunori Masaki[SUP] 1 [/SUP], Hirofumi Kamata[SUP] 1 [/SUP], Norihiro Harada[SUP] 7 [/SUP], Tetsuya Ueda[SUP] 8 [/SUP], Soichiro Ueda[SUP] 9 [/SUP], Takashi Ishiguro[SUP] 10 [/SUP], Ken Arimura[SUP] 11 [/SUP], Fukuki Saito[SUP] 12 [/SUP], Takashi Yoshiyama[SUP] 13 [/SUP], Yasushi Nakano[SUP] 14 [/SUP], Yoshikazu Muto[SUP] 15 [/SUP], Yusuke Suzuki[SUP] 5 6 [/SUP], Ryuya Edahiro[SUP] 16 [/SUP], Koji Murakami[SUP] 17 [/SUP], Yasunori Sato[SUP] 18 [/SUP], Yukinori Okada[SUP] 16 19 20 [/SUP], Ryuji Koike[SUP] 21 [/SUP], Makoto Ishii[SUP] 1 22 [/SUP], Naoki Hasegawa[SUP] 23 [/SUP], Yuko Kitagawa[SUP] 24 [/SUP], Katsushi Tokunaga[SUP] 25 [/SUP], Akinori Kimura[SUP] 26 [/SUP], Satoru Miyano[SUP] 27 [/SUP], Seishi Ogawa[SUP] 28 29 [/SUP], Takanori Kanai[SUP] 30 [/SUP], Koichi Fukunaga[SUP] 1 [/SUP], Seiya Imoto[SUP] #[/SUP][SUP] 31 [/SUP]



Affiliations
Abstract

Predictive models for determining coronavirus disease 2019 (COVID-19) severity have been established; however, the complexity of the interactions among factors limits the use of conventional statistical methods. This study aimed to establish a simple and accurate predictive model for COVID-19 severity using an explainable machine learning approach. A total of 3,301 patients ≥ 18 years diagnosed with COVID-19 between February 2020 and October 2022 were included. The discovery cohort comprised patients whose disease onset fell before October 1, 2020 (N = 1,023), and the validation cohort comprised the remaining patients (N = 2,278). Pointwise linear and logistic regression models were used to extract 41 features. Reinforcement learning was used to generate a simple model with high predictive accuracy. The primary evaluation was the area under the receiver operating characteristic curve (AUC). The predictive model achieved an AUC of ≥ 0.905 using four features: serum albumin levels, lactate dehydrogenase levels, age, and neutrophil count. The highest AUC value was 0.906 (sensitivity, 0.842; specificity, 0.811) in the discovery cohort and 0.861 (sensitivity, 0.804; specificity, 0.675) in the validation cohort. Simple and well-structured predictive models were established, which may aid in patient management and the selection of therapeutic interventions.

Keywords: Artificial intelligence; COVID-19; Machine learning.

 
Back
Top Bottom